Cargando…
Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients
BACKGROUND: The anaplastic lymphoma kinase (ALK) protein has recently become a promising target in the treatment of non-small cell lung carcinomas(NSCLC) patients with ALK translocation because of the high response rates obtained with an ALK inhibitor. ALK translocations are present in approximately...
Autores principales: | Gao, Qiqi, Ma, Honghai, Wang, Bo, Yao, Yake, Zhou, Jianya, Zhou, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752485/ https://www.ncbi.nlm.nih.gov/pubmed/29312572 http://dx.doi.org/10.18632/oncotarget.22294 |
Ejemplares similares
-
Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT
por: Wang, Yuehong, et al.
Publicado: (2015) -
Significant Radiologic Response of Pancreatic Metastasis After Targeted Therapy of Ceritinib (LDK378) for ALK-Rearranged Lung Adenocarcinoma Presenting With Hyperglycemia
por: Zheng, Jing, et al.
Publicado: (2017) -
Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening
por: Zhou, Jianya, et al.
Publicado: (2014) -
Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis
por: Zhang, Shumeng, et al.
Publicado: (2016) -
Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis
por: Ma, Wei, et al.
Publicado: (2017)